[1] |
Pezzuto JM. Resveratrol: twenty years of growth, development and controversy. Biomol Ther (Seoul), 2019; 27, 1−14. doi: 10.4062/biomolther.2018.176 |
[2] |
Noh K, Kang YR, Nepal MR, et al. Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs. Arch Pharm Res, 2017; 40, 1345−5. doi: 10.1007/s12272-017-0986-y |
[3] |
Qiao Y, Sun J, Xia S, et al. Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food Funct, 2014; 5, 1241−9. doi: 10.1039/c3fo60630a |
[4] |
Zhao L, Zhang Q, Ma WN, et al. A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota. Food Funct, 2017; 8, 4644−56. doi: 10.1039/C7FO01383C |
[5] |
Springer M, Moco S. Resveratrol and its human metabolites-effects on metabolic health and obesity. Nutrients, 2019; 11, 143. doi: 10.3390/nu11010143 |
[6] |
Shoaie S, Ghaffari P, Kovatcheva-Datchary P, et al. Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab, 2015; 22, 320−31. doi: 10.1016/j.cmet.2015.07.001 |
[7] |
Currò D, Ianiro G, Pecere S, et al. Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. Br J Pharmacol, 2017; 174, 1426−49. doi: 10.1111/bph.13632 |
[8] |
Yang B, Xiao L, Liu S, et al. Exploration of the effect of probiotics supplementation on intestinal microbiota of food allergic mice. Am J Transl Res, 2017; 9, 376−85. |
[9] |
Song JJ, Tian WJ, Kwok LY, et al. Effects of microencapsulated Lactobacillus plantarum LIP-1 on the gut microbiota of hyperlipidaemic rats. Br J Nutr, 2017; 118, 481−92. doi: 10.1017/S0007114517002380 |
[10] |
Tsiaoussis J, Antoniou MN, Koliarakis I, et al. Effects of single and combined toxic exposures on the gut microbiome: Current knowledge and future directions. Toxicol Lett, 2019; 312, 72−97. doi: 10.1016/j.toxlet.2019.04.014 |